NetworkNewsBreaks – CytoDyn Inc. (CYDY) Interim CMO to Present at 11th Annual Conference on Stem Cell and Regenerative Medicine

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning announced that Richard G. Pestell, M.D., Ph.D., president of the Pennsylvania Cancer and Regenerative Medicine Research Center, distinguished professor at the Baruch S. Blumberg Institute and interim chief medical officer of CytoDyn, will deliver the keynote plenary speech at the 11th Annual Conference on Stem Cell and Regenerative Medicine in Helsinki, Finland. Pestell’s presentation, titled ‘Cancer stem cells, genetic drivers and therapeutic targeting via CCR5’, is scheduled to take place on Monday, October 15, from 10-11 am EEST. Pestell will present recent scientific evidence demonstrating the effectiveness of PRO 140 (leronlimab), which is shown to bind to CCR5 in human breast cancer, block CCR5 signaling induced by cytokines and block human breast cancer cell invasion.

To view the full press release, visit http://nnw.fm/SgzM0

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Ships Initial Purchase Order from the NSLC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

Latest News

Power, Penske collect Indy 500 trophies

Jan 17, 2019

DETROIT — Last year, Will Power finally broke through and won the Indianapolis 500, so he can cross that accomplishment off the list. Now 37, Power is reaching an age when it's fair to wonder how much longer he'll keep at it. "I'm really enjoying my racing. I've never been so motivated. I'm fitter than I've ever been, mentally on the game," Power said. "I think once you get to this part of your career, you realize that you're not going to be doing this forever. So you've got to enjoy it and you've got to go for it when...

AP Explains: Who are al-Shabab attackers of Kenya hotel?

Jan 17, 2019

JOHANNESBURG — The overnight attack on a hotel complex in Nairobi that left 14 dead was quickly claimed by the Islamic extremist group al-Shabab, which has targeted Kenya with several devastating assaults in recent years, leaving hundreds dead. Here's a look at the group which has been called the deadliest in Africa: ___ WHAT IS AL-SHABAB? Al-Shabab, meaning "the youth" in Arabic, emerged in neighboring Somalia more than a decade ago as the chaotic Horn of Africa country was deep in warlord-led fighting. The extremist group, linked to al-Qaida, has been fighting to establish an Islamic state in Somalia based...

APNewsBreak: New pen may allow sale of horses for slaughter

Jan 17, 2019

RENO, Nev. — The U.S. Forest Service has built a new corral for wild horses in Northern California, which could allow it to bypass federal restrictions and sell the animals for slaughter. The agency acknowledged in court filings in a potentially precedent-setting legal battle that it built the pen for mustangs gathered in the fall on national forest land along the California-Nevada border because of restrictions on such sales at other federal holding facilities. The agency denies claims by horse advocates it has made up its mind to sell the more than 250 horses for slaughter. But it also says...

Trump's Cuba policy hurts private sector, new figures say

Jan 17, 2019

HAVANA — President Donald Trump's Cuba policy is driving hundreds of millions of dollars from the island's private entrepreneurs to its military-controlled tourism sector, the opposite of its supposed goal, new statistics say. Trump announced in June 2017 that he was tightening limits on U.S. travel to Cuba in order to starve military-linked travel businesses and funnel money directly to the Cuban people. He restricted Americans' ability to travel to Cuba on their own, rather than with a tour group. At the same time, he allowed U.S. cruise lines to continue to take passengers to Cuba, where they pay millions...

Civil Rights museum apologizes over Angela Davis decision

Jan 17, 2019

BIRMINGHAM, Ala. — An Alabama civil rights museum is apologizing for the discord that resulted from its decision to rescind a human rights award to political activist Angela Davis. A statement issued Monday by the Birmingham Civil Rights Institute says the organization created division and compromised its good name with the move. The statement says board members accept responsibility for what happened and are sorry. Davis is an outspoken supporter of the Palestinian cause. The board withdrew her award after a local group that educates Alabamians about the Holocaust asked them to reconsider the honor. Three members of the institute's...

Search

Welcome to The Zig Zag World. This travel blog will help you to make the most out of your travel time with interesting destination guides. Our paths will definitely cross some day as we zigzag around the world.

Contact us: sales@thezigzagworld.com